EYEPOINT PHARMACEUTICALS INC (EYPT) Institutional Ownership and Insiders Activity
EYEPOINT PHARMACEUTICALS INC (EYPT) is widely held by institutional investors, with 183 firms reporting positions valued at approximately $823.57M based on SEC Form 13F filings for the quarter ended September 30, 2026.
Janus Henderson Group Plc is the largest disclosed holder, reporting approximately $30.49M in EYPT holdings in its latest filing.
Recent insider activity includes 3 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
183
Total Reported Value
$823.57M
Largest Holder
Janus Henderson Group Plc
Largest Position
$30.49M
Insider Transactions (90d)
3
Latest Filing Quarter
Q3 2026
New Institutional Positions
157
Funds Exiting Positions
1
Top Institutional Owners
View allInvestorReported Balance
- Janus Henderson Group Plc$30.49M
- Suvretta Capital Management, Llc$28.66M
- Blackrock, Inc.$26.10M
- Cormorant Asset Management, Lp$18.80M
- Adage Capital Partners Gp, L.L.C.$16.35M
EYPT News
All news- Essex Woodlands Portfolio Concentration: An All-Healthcare Holding Analysis
Aug 7, 2026 · valut.ai
Related EYPT Institutional Insights:
- EYPT 13F Institutional Holders
- EYPT Superinvestors
- EYPT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- EYPT Insider Trading & SEC Form 4 Activity
- EYPT Articles
- Top Institutional Investor Stock Rankings